Suchergebnisse - "Sato, Shuntaro"

PubPharm (7)

1

Evaluating the safety profile of calcineurin inhibitors : cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study

enthalten in: Arthritis research & therapy | 2024

von Ichinose, K. | Sato, S. | Igawa, T. | +22

2

Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone : an open-label, randomized, parallel-group study

enthalten in: Arthritis research & therapy | 2022

von Iwamoto, N. | Chiba, K. | Sato, S. | +15

3

Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis

enthalten in: Arthritis research & therapy | 2021

von Iwamoto, N. | Sato, S. | Kurushima, S. | +22

4

Comparison of complete renal response and mortality in early- and late-onset lupus nephritis : a multicenter retrospective study of a Japanese cohort

enthalten in: Arthritis research & therapy | 2020

von Ichinose, K. | Kitamura, M. | Sato, S. | +16

5

Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis

enthalten in: Arthritis research & therapy | 2020

von Koga, T. | Sumiyoshi, R. | Furukawa, K. | +17

6

Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years

enthalten in: Arthritis research & therapy | 2016

von Fukui, S. | Iwamoto, N. | Shimizu, T. | +16

7

Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years

enthalten in: Arthritis research & therapy | 2016

von Fukui, S. | Iwamoto, N. | Shimizu, T. | +16

1
[1]